In conclusion, our study revealed that the KL-6, SP-D, VEGF-A, IGFBP-1, ICAM-1 and CCL18 serum levels were significantly elevated in IPF patients with disease progression and death. This evidence concerns the gene VEGFA and idiopathic pulmonary fibrosis.